Author

Mohamed Salama

Beni-Suef UniversityORCID 0000-0002-0002-9108Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Yusuf Awni HannuniD· 2 shared Albert Kwaku AkpaluiD· 1 shared Alex MedinaiD· 1 shared Alexander A. ZimprichiD· 1 shared Alexis BriceiD· 1 shared Altynay KarimovaiD· 1 shared Alvaro Hernandez· 1 shared Amy HuangiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Yusuf Awni HannunORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

KPB82 potently and selectively inhibits ACER2 and protects tumor and primary cells from doxorubicin-induced cytotoxicity

Arpita Devi, Ruijuan Xu, Szulc Zdzislaw, Ian Kim, Mohamed Salama, Krishna P. Bhabak, Christoph Arenz, Daniel Canals, Yusuf Awni Hannun, Cungui Mao

This paper identifies KPB82 as a potent and selective ACER2 inhibitor that reduces doxorubicin-induced cytotoxicity in multiple cell types.

bioRxiv · Oct 2, 2026 · PreprintBiochemistry

TKI-Tolerant Persisters Emerge from a PKCα-Dependent and Highly Plastic Subpopulation of Stem-Like Cells in NSCLC

Mojtaba Sadeghi, Mohamed Salama, Sagarika Choudhury, Amy Huang, Jie Yang, Yusuf Awni Hannun

This study identifies PKCα as a critical regulator of drug-tolerant persister cells in NSCLC, showing its role in enabling survival and relapse after TKI treatment.

bioRxiv · May 21, 2026 · PreprintCancer Biology

TMEM175, SCARB2 and CTSB associations with Parkinson's disease risk across populations.

Wenhua Sun, Claudia Schulte, Thomas Gasser, Manuela M. X. Tan, the Global Parkinson’s Genetic Program (GP2), Lasse Pihlstrøm, Pedro Chaná, Yeajin Song, Sara Bandrés‐Ciga, Cornelis Blauwendraat, Andrew Singleton, Mike A. Nalls, Hampton L. Leonard, Mie Rizig, Hirotaka Iwaki, , Rejko Krüger

This study identifies genetic associations between lysosomal genes and Parkinson's disease risk across diverse populations using GWAS and whole genome sequencing data.

npj Parkinson s Disease · Dec 2, 2025Peer-reviewedGenetic & Genomic Medicine